Xuyong Wei

3.4k citations
127 papers · 2.3k indexed · h-index 26
Topics
Liver Disease Diagnosis and Treatment (24 papers)Hepatocellular Carcinoma Treatment and Prognosis (21 papers)Organ Transplantation Techniques and Outcomes (20 papers)
Journals
Advanced MaterialsAngewandte Chemie International EditionSHILAP Revista de lepidopterología

In The Last Decade

Xuyong Wei

111 papers receiving 2.3k citations

Peers

Xuyong Wei
Comparison fields: 5 of 104
  • Molecular Biology 1.1k
  • Hepatology 605
  • Surgery 464
  • Cancer Research 463
  • Epidemiology 414
Replace Kaishan Tao with:
Kaishan Tao China
Guihua Chen China
Liyong Pu China
Seiki Tashiro Japan
Niccola Funel Italy
Qichang Zheng China
Kim R. Bridle Australia
Zifang Song China
Yitao Ding China
Stefania Cannito Italy
Xuyong Wei relative to Kaishan Tao China Kaishan Tao's profile →
Citations per field
00.5×1.5×
Kaishan Tao · 1×
Citations per year

Countries citing papers authored by Xuyong Wei

Since Specialization
Citations

This map shows the geographic impact of Xuyong Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuyong Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuyong Wei more than expected).

Fields of papers citing papers by Xuyong Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuyong Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuyong Wei. The network helps show where Xuyong Wei may publish in the future.

Co-authorship network of co-authors of Xuyong Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Xuyong Wei. A scholar is included among the top collaborators of Xuyong Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuyong Wei. Xuyong Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 3
5 0
6 6
7 10
8 0
9 5
10 3
11 0
12 5
13 12
14 46
15 7
16 33
17 10
18 13
19 46
20 83

About Xuyong Wei

Xuyong Wei is a scholar working on Hepatology, Transplantation and Cancer Research, having authored 127 papers that have together received 2.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (24 papers), Hepatocellular Carcinoma Treatment and Prognosis (21 papers) and Organ Transplantation Techniques and Outcomes (20 papers). The work is most often cited by research in Hepatology (605 citations), Cancer Research (463 citations) and Transplantation (75 citations). Xuyong Wei has collaborated with scholars based in China, Madagascar and United States. Frequent co-authors include Xiao Xu, Haiyang Xie, Shusen Zheng, Lin Zhou, Qi Ling, Di Lu, Shusen Zheng, Hangxiang Wang, Jianguo Wang and Jiaping Wu. Their work appears in journals such as Advanced Materials, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026